Virginia G Johnson

Title: Virginia G Johnson: Innovator in Immunotoxin Development

Introduction

Virginia G Johnson is a prominent inventor based in College Park, MD (US). She has made significant contributions to the field of immunotoxins, holding a total of 4 patents. Her work focuses on developing targeted therapies for various types of tumors, particularly those affecting the central nervous system.

Latest Patents

Among her latest patents, Johnson has developed mutant diphtheria toxin conjugates. These immunotoxins are designed to specifically target human tumors and leukemias, providing a potent treatment option without the toxicity associated with native toxins. Another notable patent involves the treatment of tumors of neurologic origin, where immunotoxins are conjugated to moieties that bind to tumor cell receptors. This innovative approach aims to treat primary tumors and metastatic tumors effectively.

Career Highlights

Throughout her career, Johnson has worked with esteemed organizations, including the United States of America as represented by the Secretary of Health and Human Services and Cetus Corporation. Her research has paved the way for advancements in cancer treatment, particularly in the development of immunotoxins that can selectively kill tumor cells.

Collaborations

Johnson has collaborated with notable colleagues in her field, including Richard J Youle and Larry Greenfield. These partnerships have contributed to her success and the advancement of her research.

Conclusion

Virginia G Johnson's innovative work in immunotoxin development has made a significant impact on cancer treatment. Her patents reflect her dedication to improving therapeutic options for patients with challenging tumors.